Monthly Archives: September, 2014

One Gene Mutation Identified for a Subset of People with Irritable Bowel Syndrome (IBS)

A September 5, 2014 news item from IFFGD reports that a gene mutation that appears to relate to irritable bowel syndrome has been identified in a genetic region known as SCN5A. SCN5A controls part of the function of the sodium channel, which is necessary for normal gastrointestinal motility. This news item was based on a …

Continue reading

When Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) Overlap or Coexist

Although inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) have similar acronyms and some similar symptoms, they are very different gastrointestinal disorders. The different forms of IBD, such as Crohn’s disease and ulcerative colitis, cause visible inflammation and other structural changes in the digestive tract, as well as tangible biomarkers in one’s blood that …

Continue reading

Representative King of New York Co-Sponsors HR 842 for Functional Gastrointestinal and Motility Disorders

UPDATE: 06/13/2015: HR 842 did not pass, but a similar bill HR 2311 is currently in the House of Representatives for 2015-2016. Please click on the HR 2311 sub-category on the right sidebar of this blog to see the relevant posts. According to THOMAS, the Library of Congress legislative database, and IFFGD/the Digestive Health¬†Alliance, Representatives …

Continue reading

Clinical Trial: Probiotics and Fish Oil for IBS, University of Sheffield, UK, 2014

The Medical School at the University of Sheffield¬† in the United Kingdom is currently seeking 74 volunteers with IBS to take part in a clinical trial on how and why probiotics and fish oil may affect abdominal pain, bloating, anxiety and memory and overall function of the lower gastrointestinal tract. ¬† Participants will take either …

Continue reading